Quick T-cell test for hepatitis B and D
Part of Infections clinical trials.
This study is testing a new blood test that quickly checks your T-cells (part of your immune system). It is for people with chronic hepatitis B or both hepatitis B and D.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You have chronic hepatitis B, or both hepatitis B and hepatitis D.
- You do NOT have hepatitis C or HIV.
- You are not taking drugs that weaken your immune system.
- You do not have any other immune system problem.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study evaluates a new blood test that checks for HIV, hepatitis B, hepatitis C, and syphilis all at once. It is designed to see how well the test works in different groups of people, including those with known infections and those without.
This trial tests a drug called bulevirtide for people with chronic hepatitis B and D (HDV) co-infection. It looks at how the immune system and virus respond to treatment.
This study tests whether people with both HIV and chronic hepatitis B should be checked for a third liver virus called HDV (hepatitis D). It helps find hidden infections so they can get the right care.
This study is testing a newer, more precise way of measuring the amount of hepatitis B virus in your blood (called digital PCR) to see if it matches current testing methods. If you are a chronic hepatitis B patient, this could help make future virus monitoring more accurate.
This study looks at new blood tests (biomarkers) to better understand chronic hepatitis B and how it affects treatment decisions. It may help doctors find better ways to manage your condition.
This study tests a quick blood test to check migrants and refugees for hepatitis B and D. It aims to find infections early so people can get the right care.
Hear when a new HBV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.